These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19299522)

  • 1. Development of a high-throughput brain slice method for studying drug distribution in the central nervous system.
    Fridén M; Ducrozet F; Middleton B; Antonsson M; Bredberg U; Hammarlund-Udenaes M
    Drug Metab Dispos; 2009 Jun; 37(6):1226-33. PubMed ID: 19299522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Longhi R; Corbioli S; Fontana S; Vinco F; Braggio S; Helmdach L; Schiller J; Boriss H
    Drug Metab Dispos; 2011 Feb; 39(2):312-21. PubMed ID: 21071520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
    Fridén M; Bergström F; Wan H; Rehngren M; Ahlin G; Hammarlund-Udenaes M; Bredberg U
    Drug Metab Dispos; 2011 Mar; 39(3):353-62. PubMed ID: 21149540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
    Wan H; Rehngren M
    J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.
    Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1254-62. PubMed ID: 15743928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
    Wan H; Rehngren M; Giordanetto F; Bergström F; Tunek A
    J Med Chem; 2007 Sep; 50(19):4606-15. PubMed ID: 17725338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids.
    Fridén M; Gupta A; Antonsson M; Bredberg U; Hammarlund-Udenaes M
    Drug Metab Dispos; 2007 Sep; 35(9):1711-9. PubMed ID: 17591680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration.
    Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
    Drug Metab Dispos; 2006 Sep; 34(9):1443-7. PubMed ID: 16760229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput microsomal stability assay for insoluble compounds.
    Di L; Kerns EH; Li SQ; Petusky SL
    Int J Pharm; 2006 Jul; 317(1):54-60. PubMed ID: 16621364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing brain free fraction in early drug discovery.
    Read KD; Braggio S
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):337-44. PubMed ID: 20102287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?
    Hammarlund-Udenaes M
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):215-20. PubMed ID: 20050843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid.
    Liu X; Van Natta K; Yeo H; Vilenski O; Weller PE; Worboys PD; Monshouwer M
    Drug Metab Dispos; 2009 Apr; 37(4):787-93. PubMed ID: 19116265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to optimize brain penetration in drug discovery.
    Liu X; Chen C
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):505-12. PubMed ID: 16022187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of whole-body autoradioluminography in drug discovery for the quantification of tritium-labeled drug candidates.
    Potchoiba MJ; Nocerini MR
    Drug Metab Dispos; 2004 Oct; 32(10):1190-8. PubMed ID: 15377642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
    He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
    Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.
    Yoon CH; Kim SJ; Shin BS; Lee KC; Yoo SD
    J Biomol Screen; 2006 Feb; 11(1):13-20. PubMed ID: 16314407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
    Summerfield SG; Read K; Begley DJ; Obradovic T; Hidalgo IJ; Coggon S; Lewis AV; Porter RA; Jeffrey P
    J Pharmacol Exp Ther; 2007 Jul; 322(1):205-13. PubMed ID: 17405866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.